Clinical activity of pembrolizumab in a patient with metastatic triple- negative breast cancer without tumor programmeddeath-ligand 1 expression: A case report and correlative biomarker analysis

Sajjad Bhatti; Jaimie Heldstab; Carolyn Lehn; Ossama Tawfik; Ryan M. Ash; David R. Hout; Rob S. Seitz; Daniel B. Bailey; Anne P. O'Dea; Roy A. Jensen; Fang Fan; Qamar J. Khan; Andrew K. Godwin; Priyanka Sharma

doi:10.1200/PO.17.00032

Clinical activity of pembrolizumab in a patient with metastatic triple- negative breast cancer without tumor programmeddeath-ligand 1 expression: A case report and correlative biomarker analysis

Sajjad Bhatti
, Jaimie Heldstab
, Carolyn Lehn
, Ossama Tawfik
, Ryan M. Ash
, David R. Hout
, Rob S. Seitz
, Daniel B. Bailey
, Anne P. O'Dea
, Roy A. Jensen
, Fang Fan
, Qamar J. Khan
, Andrew K. Godwin
, Priyanka Sharma

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Original language	English
Pages (from-to)	1-6
Number of pages	6
Journal	JCO Precision Oncology
Volume	2017
Issue number	1
DOIs	https://doi.org/10.1200/PO.17.00032
State	Published - 2017
Externally published	Yes

Access to Document

10.1200/PO.17.00032

Cite this

Bhatti, S., Heldstab, J., Lehn, C., Tawfik, O., Ash, R. M., Hout, D. R., Seitz, R. S., Bailey, D. B., O'Dea, A. P., Jensen, R. A., Fan, F., Khan, Q. J., Godwin, A. K., & Sharma, P. (2017). Clinical activity of pembrolizumab in a patient with metastatic triple- negative breast cancer without tumor programmeddeath-ligand 1 expression: A case report and correlative biomarker analysis. JCO Precision Oncology, 2017(1), 1-6. https://doi.org/10.1200/PO.17.00032

@article{788bf3556e944036b1b6d31df6cbabc8,

title = "Clinical activity of pembrolizumab in a patient with metastatic triple- negative breast cancer without tumor programmeddeath-ligand 1 expression: A case report and correlative biomarker analysis",

author = "Sajjad Bhatti and Jaimie Heldstab and Carolyn Lehn and Ossama Tawfik and Ash, \{Ryan M.\} and Hout, \{David R.\} and Seitz, \{Rob S.\} and Bailey, \{Daniel B.\} and O'Dea, \{Anne P.\} and Jensen, \{Roy A.\} and Fang Fan and Khan, \{Qamar J.\} and Godwin, \{Andrew K.\} and Priyanka Sharma",

year = "2017",

doi = "10.1200/PO.17.00032",

language = "English",

volume = "2017",

pages = "1--6",

journal = "JCO Precision Oncology",

issn = "2473-4284",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

Bhatti, S, Heldstab, J, Lehn, C, Tawfik, O, Ash, RM, Hout, DR, Seitz, RS, Bailey, DB, O'Dea, AP, Jensen, RA, Fan, F, Khan, QJ, Godwin, AK & Sharma, P 2017, 'Clinical activity of pembrolizumab in a patient with metastatic triple- negative breast cancer without tumor programmeddeath-ligand 1 expression: A case report and correlative biomarker analysis', JCO Precision Oncology, vol. 2017, no. 1, pp. 1-6. https://doi.org/10.1200/PO.17.00032

Clinical activity of pembrolizumab in a patient with metastatic triple- negative breast cancer without tumor programmeddeath-ligand 1 expression: A case report and correlative biomarker analysis. / Bhatti, Sajjad; Heldstab, Jaimie; Lehn, Carolyn et al.
In: JCO Precision Oncology, Vol. 2017, No. 1, 2017, p. 1-6.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Clinical activity of pembrolizumab in a patient with metastatic triple- negative breast cancer without tumor programmeddeath-ligand 1 expression

T2 - A case report and correlative biomarker analysis

AU - Bhatti, Sajjad

AU - Heldstab, Jaimie

AU - Lehn, Carolyn

AU - Tawfik, Ossama

AU - Ash, Ryan M.

AU - Hout, David R.

AU - Seitz, Rob S.

AU - Bailey, Daniel B.

AU - O'Dea, Anne P.

AU - Jensen, Roy A.

AU - Fan, Fang

AU - Khan, Qamar J.

AU - Godwin, Andrew K.

AU - Sharma, Priyanka

PY - 2017

Y1 - 2017

UR - https://www.scopus.com/pages/publications/85052520326

U2 - 10.1200/PO.17.00032

DO - 10.1200/PO.17.00032

M3 - Article

AN - SCOPUS:85052520326

SN - 2473-4284

VL - 2017

SP - 1

EP - 6

JO - JCO Precision Oncology

JF - JCO Precision Oncology

IS - 1

ER -